Article
[Abnormal antithrombin III: abnormalities of heparin or protease binding domain].
Rinsho byori. The Japanese journal of clinical pathology - 1 May 1993
Sakuragawa N, Niiya K, Takahashi K, Hayashi T, Oguma Y, Saitoh S
Abstract excerpt
Two patients with abnormal antithrombin III manifested abnormality in heparin binding activity (abnormal antithrombin III "Toyma") or protease binding activity (abnormal antithrombin III "Aomori"). Antithrombin III "Toyama" is hereditarily homozygous with Arg47 to Cys47 (TGC-->TGT) mutation, and antithrombin III "Aomori" is hereditarily heterozygous with Arg393 to His393 (CGT-->CAT). The former is classified as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.